Total Payments
$1,454
2024 Payments
$407.04
Companies
21
Transactions
79
Medicare Patients
683
Medicare Billing
$30,474
Payment Breakdown by Category
Food & Beverage$1,454 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,454 | 79 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $269.31 | 22 | $0 (2023) |
| Janssen Biotech, Inc. | $220.46 | 10 | $0 (2024) |
| Lilly USA, LLC | $212.74 | 7 | $0 (2024) |
| Boston Scientific Corporation | $127.54 | 3 | $0 (2019) |
| Merck Sharp & Dohme LLC | $118.68 | 8 | $0 (2024) |
| Amgen Inc. | $108.82 | 5 | $0 (2019) |
| PFIZER INC. | $74.07 | 6 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $44.70 | 2 | $0 (2022) |
| AbbVie Inc. | $36.63 | 2 | $0 (2021) |
| Intercept Pharmaceuticals, Inc. | $33.89 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $407.04 | 16 | Lilly USA, LLC ($212.74) |
| 2023 | $238.04 | 20 | Celgene Corporation ($196.15) |
| 2022 | $244.62 | 16 | Celgene Corporation ($73.16) |
| 2021 | $97.69 | 5 | Janssen Biotech, Inc. ($45.19) |
| 2020 | $57.93 | 3 | Almirall LLC ($23.53) |
| 2019 | $175.84 | 8 | Boston Scientific Corporation ($53.29) |
| 2018 | $160.82 | 7 | Boston Scientific Corporation ($74.25) |
| 2017 | $72.03 | 4 | Amgen Inc. ($40.73) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $33.76 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $34.21 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $33.41 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Immunology | ||||||
| 07/24/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $34.26 | General |
| Category: Immunology | ||||||
| 07/05/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/12/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/31/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Immunology | ||||||
| 05/30/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $33.02 | General |
| Category: Immunology | ||||||
| 04/03/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 03/22/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: Immunology | ||||||
| 02/21/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Immunology | ||||||
| 01/31/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $32.97 | General |
| Category: Immunology | ||||||
| 01/30/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/24/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Immunology | ||||||
| 12/05/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.33 | General |
| Category: Neuroscience | ||||||
| 11/29/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: RESPIRATORY | ||||||
| 11/29/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $2.08 | General |
| Category: Neuroscience | ||||||
| 10/31/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.52 | General |
| Category: Neuroscience | ||||||
| 10/10/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.04 | General |
| Category: Neuroscience | ||||||
| 09/29/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.02 | General |
| Category: Neuroscience | ||||||
| 08/31/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.43 | General |
| Category: Neuroscience | ||||||
| 08/04/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.67 | General |
| Category: Neuroscience | ||||||
| 08/04/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.80 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 288 | 293 | $45,200 | $12,867 |
| 2022 | 2 | 124 | 124 | $18,117 | $5,738 |
| 2021 | 2 | 137 | 137 | $19,916 | $6,444 |
| 2020 | 2 | 134 | 136 | $19,365 | $5,425 |
Total Patients
683
Total Services
690
Medicare Billing
$30,474
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 108 | $15,335 | $4,268 | 27.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 73 | 73 | $13,295 | $3,646 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 42 | 42 | $5,761 | $2,035 | 35.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 21 | 21 | $3,786 | $1,064 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $2,390 | $891.72 | 37.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 15 | 15 | $2,447 | $504.46 | 20.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 22 | $2,186 | $459.00 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 63 | $8,283 | $2,814 | 34.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 43 | 43 | $7,476 | $2,197 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 18 | 18 | $2,358 | $727.62 | 30.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 72 | $9,294 | $3,090 | 33.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 37 | 37 | $6,498 | $1,767 | 27.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 16 | 16 | $2,072 | $824.00 | 39.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 12 | 12 | $2,052 | $762.72 | 37.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 97 | 99 | $13,121 | $3,662 | 27.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 37 | 37 | $6,244 | $1,763 | 28.2% |
About Dr. James Allen, MD
Dr. James Allen, MD is a Internal Medicine healthcare provider based in Shawnee, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144300716.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Allen, MD has received a total of $1,454 in payments from pharmaceutical and medical device companies, with $407.04 received in 2024. These payments were reported across 79 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,454).
As a Medicare-enrolled provider, Allen has provided services to 683 Medicare beneficiaries, totaling 690 services with total Medicare billing of $30,474. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Shawnee, KS
- Active Since 10/17/2006
- Last Updated 09/13/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1144300716
Products in Payments
- ZEPOSIA (Drug) $255.12
- OMVOH (Drug) $212.74
- STELARA (Biological) $150.26
- DIFICID (Drug) $88.86
- XELJANZ (Drug) $63.04
- GENERAL HEMOSTASIS (Device) $53.82
- ORISE (Device) $53.29
- Aimovig (Biological) $49.20
- Prolia (Biological) $40.73
- REMICADE (Biological) $35.99
- TREMFYA (Drug) $34.21
- OCALIVA (Drug) $33.89
- JANUVIA (Drug) $29.82
- XIFAXAN (Drug) $27.01
- ENDOFLIP (Device) $25.48
- Seysara (Drug) $23.53
- Creon (Drug) $22.81
- Tresiba (Drug) $20.47
- GENERAL POLYPECTOMY (Device) $20.43
- FARXIGA (Drug) $20.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Shawnee
Dr. Isma Javed, M.d, M.D
Internal Medicine — Payments: $14,621
Internal Medicine $14,621
Dr. Jeremy Holter, Md, MD
Internal Medicine — Payments: $2,028
Internal Medicine $2,028
Dr. Kelli Koons, M.d, M.D
Internal Medicine — Payments: $1,847
Internal Medicine $1,847
Dr. Phillip Haddad, M.d, M.D
Internal Medicine — Payments: $1,418
Internal Medicine $1,418
Danielle Stebbins, Md, MD
Internal Medicine — Payments: $1,237
Internal Medicine $1,237
Amber Niewald, Md, MD
Internal Medicine — Payments: $838.72
Internal Medicine $838.72